SYNDAX PHARMACEUTICALS INC SNDX

US Healthcare Pharmaceutical Preparations
$21.82
+4.5%
52w: $8.73 – $25.15

Latest 13F among current holders filed 11 days ago (Jun 24, 2026)

Price — last 12 months

research preview data
8.7316.9425.15
Jun 20, 2025 Jul 2, 2026
Institutional holders
246
+17 QoQ
13F value
$2.35B
+11.9% QoQ
Smart-money holders
26
signal tier ≥ 2
New smart buyers
2
Q1 2026
Options barometer
1.9×
$15.3M calls / $8.1M puts

Institutional value by quarter

$2.27B
Q1 2024
$1.82B
Q2 2024
$1.71B
Q3 2024
$1.30B
Q4 2024
$1.26B
Q1 2025
$942.4M
Q2 2025
$1.56B
Q3 2025
$2.10B
Q4 2025
$2.35B
Q1 2026

Number of holders

191
Q1 2024
197
Q2 2024
211
Q3 2024
217
Q4 2024
220
Q1 2025
218
Q2 2025
228
Q3 2025
229
Q4 2025
246
Q1 2026

Who owns SNDX?

Q1 2026 filings
FundTypeSharesValue% of fundChange
BlackRock, Inc. Index provider8.3M$192.8M0.0%+0.2%
Kynam Capital Management, LP ★3Fundamental concentrated8.1M$188.1M11.9%Held
GOLDMAN SACHS GROUP INC Bank broker5.0M$116.7M0.0%-12.3%
STATE STREET CORP Index provider4.4M$103.5M0.0%-3.6%
BANK OF AMERICA CORP /DE/ Bank broker4.2M$99.3M0.0%-9.8%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical3.8M$89.3M0.0%
DEERFIELD MANAGEMENT COMPANY, L.P. Quant stat arb3.8M$88.3M1.2%New
Eversept Partners, LP ★2Fundamental diversified2.9M$67.4M4.4%-12.9%
KINGDON CAPITAL MANAGEMENT, L.L.C. Other2.5M$58.4M9.8%+6.4%
STEMPOINT CAPITAL LP ★2Fundamental concentrated2.4M$56.8M5.5%+81.5%
Hood River Capital Management LLC Other2.4M$55.0M0.6%+1.6%
GEODE CAPITAL MANAGEMENT, LLC Index provider2.2M$50.4M0.0%+3.2%
FRANKLIN RESOURCES INC Long only active2.2M$50.2M0.0%-11.2%
Point72 Asset Management, L.P. Multistrat pod2.0M$46.4M0.1%-59.3%
Elmind Capital, LP ★3Fundamental concentrated1.9M$43.3M12.3%Held
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical1.7M$40.6M0.0%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Bank broker1.7M$40.5M0.0%+25.9%
Soleus Capital Management, L.P. ★2Fundamental diversified1.7M$40.3M1.6%-23.1%
D. E. Shaw & Co., Inc. Quant stat arb1.6M$37.4M0.0%+31.3%
TWO SIGMA INVESTMENTS, LP Quant stat arb1.6M$36.9M0.0%+37.7%
Nuveen, LLC Diversified mechanical1.5M$34.9M0.0%+0.8%
MPM BIOIMPACT LLC ★2Fundamental concentrated1.3M$31.3M2.4%+0.2%
Aisling Capital Management LP ★3Fundamental concentrated1.3M$30.8M6.5%Held
Woodline Partners LP Other1.3M$29.2M0.1%0.0%
UBS Group AG Bank broker1.2M$26.9M0.0%+61.1%
Catalio Capital Management, LP ★2Fundamental concentrated1.0M$24.4M5.1%-12.8%
Bank of New York Mellon Corp Diversified mechanical1.0M$23.5M0.0%-8.2%
Ensign Peak Advisors, Inc Diversified mechanical991.0K$23.1M0.0%-38.0%
AQR CAPITAL MANAGEMENT LLC Quant stat arb980.3K$22.9M0.0%+5.9%
ORBIMED ADVISORS LLC ★2Fundamental diversified962.3K$22.5M0.5%New
ALGERT GLOBAL LLC Diversified mechanical928.6K$21.7M0.3%+0.1%
Candriam S.C.A. Other925.3K$21.6M0.1%Held
Parkman Healthcare Partners LLC Other901.5K$21.1M2.2%+57.1%
MORGAN STANLEY Bank broker893.9K$20.9M0.0%-16.9%
SILVERARC CAPITAL MANAGEMENT, LLC ★2Fundamental diversified889.0K$20.8M2.4%+38.3%
Palo Alto Investors LP ★3Fundamental concentrated865.0K$20.2M3.1%+8.9%
Prosight Management, LP ★2Fundamental concentrated770.0K$18.0M2.9%+15.8%
NORTHERN TRUST CORP Index provider755.7K$17.7M0.0%+3.7%
SPHERA FUNDS MANAGEMENT LTD. Other724.6K$16.9M2.9%-5.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider715.2K$16.7M0.0%-1.7%
Trails Edge Capital Partners, LP ★2Fundamental concentrated701.8K$16.4M3.9%New
CITADEL ADVISORS LLC Multistrat pod630.9K$14.7M0.0%+242.9%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical600.5K$14.0M0.0%
Apis Capital Advisors, LLC ★2Fundamental concentrated550.0K$12.8M2.0%-24.0%
RENAISSANCE TECHNOLOGIES LLC Quant stat arb498.2K$11.6M0.0%-8.6%
Knott David M Jr ★2Fundamental diversified422.0K$9.9M5.9%+1.7%
Walleye Capital LLC Multistrat pod385.0K$9.0M0.1%+1490.5%
Rhenman & Partners Asset Management AB Other379.3K$8.9M1.1%-22.1%
Integral Health Asset Management, LLC ★2Fundamental diversified350.0K$8.2M0.4%+75.0%
JANE STREET GROUP, LLC Market maker335.5K$7.8M0.0%-55.2%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.